Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
Treating Younger Patients With T-Cell ALL or Stage II-IV T-Cell Lymphoblastic Lymphoma
Full IRB Study Title:
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
IRB Study ID: 986659-1
For complete study information, please view the study on clinicaltrials.gov.
